The dynamics of the acute myocardial infarction market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the disease, incremental healthcare spending worldwide, and the expected launch of emerging therapies. LAS…

– Results of pivotal confirmatory trial found the enfortumab vedotin plus pembrolizumab combination significantly extended overall survival and progression-free survival vs standard platinum containing chemotherapy– – If approved, the combination would be the first and only antibody-drug…

NEW YORK–(BUSINESS WIRE)–BuildRI, a leading provider of responsible investment insights, is pleased to unveil the leading responsible investment programs within the European alternative investment sector for the year 2023. Throughout the course of the year, BuildRI’s team of seasoned analysts has assessed multiple alternative investment firms, employing a comprehensive set of 32 responsible investment and Environmental, Social, and Governance (ESG) criteria. These criteria encompass the integ

Originally published on Forbes

By Diane Brady, Forbes Staff

To understand Dan Amos’ approach to leadership, consider the first role he took at Aflac after graduating from the University of Georgia in 1973. As son of cofounder Paul Amos, one of three brothers who founded the insurance company in 1955, he could have hung out in the head office. Instead, he started in sales.

“I wanted an objective job, not a subjective job,” says Amos, 72, who went on to become the top salesman of the supplemental health and life insurance company—and its CEO in 1990. “Goal-setting always intrigued me and was something I liked.”

Continue reading the full article on Forbes